This blog is all about current FDA approved drugs to treat the hepatitis C virus (HCV) with a focus on treating HCV according to genotype, using information extracted from peer-reviewed journals, liver meetings/conferences, and interactive learning activities.
Risk Of Developing Liver Cancer After HCV Treatment
- Home
- Newly Diagnosed With Hep C? Or Considering Treatment?
- All FDA Approved Drugs To Treat Hepatitis C
- Hepatitis C Genotypes and Treatment
- Mavyret (glecaprevir/pibrentasvir)
- Vosevi (Sofosbuvir/Velpatasvir/Voxilaprevir)
- Epclusa® (Sofosbuvir/Velpatasvir)
- Harvoni® (Ledipasvir/Sofosbuvir)
- VIEKIRA XR/VIEKIRA Pak
- Zepatier(Elbasvir/Grazoprevir)
- Cure - Achieving sustained virologic response (SVR) in hepatitis C
- HCV Liver Fibrosis
- FibroScan® Understanding The Results
- HCV Cirrhosis
- Staging Cirrhosis
- HCV Liver Cancer
- Risk Of Developing Liver Cancer After HCV Treatment
- Treating Elderly HCV Patients
- Fatty Liver Disease: NAFLD/NASH
- Current research articles on ailments that may be related to HCV
- Is There A Natural Way To Improve Liver Fibrosis?
- Can Food Or Herbs Interact With Conventional Medical Treatments?
Saturday, February 23, 2013
Hepatitis C Coalition (HCV Coalition for The Cure) Launches White House Petition to End Hepatitis C
Press Conference - (Hepatitis C) HCV Coalition for The Cure
Hepatitis C Coalition (HCV Coalition for The Cure)
Launches White House Petition to End Hepatitis C
According to the World Health Organization (WHO) 350,000 people a year are dying from Hepatitis C. Gilead Sciences and Bristol-Myers Squibb together developed a promising cure and HCV advocates are outraged at lack of its development
Fact sheets
The disease now kills more people than AIDS
San Antonian, Margaret Dudley, was diagnosed with Hepatitis C in 2011. Dudley is leading a charge to make a cure available to the four million Americans living with the disease. "We feel Gilead Sciences has a moral responsibility to work with Bristol-Myers to put an end to this epidemic disease," says Dudley.
She established the HCV Coalition for The Cure to raise awareness about Hepatitis C and the cure that exists. She says the greatest frustration is knowing that a treatment is available without toxic ribavirin and/or interferon, but it's not being used. She says two pills from two different drug makers have shown remarkable results, but their use against Hepatitis C is stalled. Dudley says drug company Gilead Sciences has balked at further development with Bristol-Myers Squibb rather than moving forward with the medications they created together to cure the most common forms of Hepatitis C, which is a combination of Gilead Sciences’ sofosbuvir combined with Bristol’s daclatasvir.
Reuters - Bristol urges combo hepatitis C study with Gilead
On February 19, 2013, Dudley, with the support of her husband, Gary Dudley, co-owner of San Antonio based corporation, SWBC, and a number of other advocates announced a drive to obtain a hundred thousand signatures, that would get the White House to help move things along.
"They can stop this disease by collaborating on this cure for a disease that's reached epidemic proportions," says 61 year old Dudley - a mother and grandmother.
The Hepatitis C virus resides in the liver. Over time, cysts and scar tissue form, causing liver cirrhosis. Tumors can develop and the liver can fail. This is the number one reason for liver transplants. "We feel very strongly with help of the nation and the White House, we can get these drug companies to come together with their previously proven treatment to cure the disease."
"You have the cure, you developed it, give us access to it," says Margaret directing her plea to the drug companies.
Dudley is urging everyone to go to http://www.hepc-cured.org and sign the White House petition.
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment